174 related articles for article (PubMed ID: 32963027)
21. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.
Loveland P; Christie M; Hammerschlag G; Irving L; Steinfort D
Intern Med J; 2018 Nov; 48(11):1318-1324. PubMed ID: 29869427
[TBL] [Abstract][Full Text] [Related]
22. Management of Malignant Pleural Effusions-What Is New.
Thomas R; Roy B; Maldonado F; Lee YCG
Semin Respir Crit Care Med; 2019 Jun; 40(3):323-339. PubMed ID: 31525808
[TBL] [Abstract][Full Text] [Related]
23. Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study.
Hsu LH; Hsu PC; Liao TL; Feng AC; Chu NM; Kao SH
BMC Cancer; 2016 Jul; 16():463. PubMed ID: 27411914
[TBL] [Abstract][Full Text] [Related]
24. Interventional therapies for malignant pleural effusions: the present and the future.
Thomas R; Francis R; Davies HE; Lee YC
Respirology; 2014 Aug; 19(6):809-22. PubMed ID: 24947955
[TBL] [Abstract][Full Text] [Related]
25. Clinical Profile of Patients Presenting with Malignant Pleural Effusion to a Tertiary Health Care Centre.
Gadewad N; Deokar K; Ghorpade S
J Assoc Physicians India; 2017 Aug; 65(8):28-31. PubMed ID: 28799302
[TBL] [Abstract][Full Text] [Related]
26. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
Pinelli V; Laroumagne S; Sakr L; Marchetti GP; Tassi GF; Astoul P
J Thorac Oncol; 2012 Mar; 7(3):595-8. PubMed ID: 22307010
[TBL] [Abstract][Full Text] [Related]
27. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
[TBL] [Abstract][Full Text] [Related]
28. Management of malignant pleural effusions.
Spector M; Pollak JS
Semin Respir Crit Care Med; 2008 Aug; 29(4):405-13. PubMed ID: 18651358
[TBL] [Abstract][Full Text] [Related]
29. Cytologically proved malignant pleural effusions: distribution of transudates and exudates.
Assi Z; Caruso JL; Herndon J; Patz EF
Chest; 1998 May; 113(5):1302-4. PubMed ID: 9596310
[TBL] [Abstract][Full Text] [Related]
30. Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.
Froudarakis ME; Plojoux J; Kaspi E; Anevlavis S; Laroumagne S; Karpathiou G; Roca E; Adler D; Dutau H; Astoul P
Clin Respir J; 2018 Mar; 12(3):1011-1016. PubMed ID: 28245530
[TBL] [Abstract][Full Text] [Related]
31. Malignant Pleural Effusion: Still a Long Way to Go.
Meriggi F
Rev Recent Clin Trials; 2019; 14(1):24-30. PubMed ID: 30514193
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer.
Lee YG; Jung I; Koo DH; Kang DY; Oh TY; Oh S; Lee SS
Support Care Cancer; 2019 May; 27(5):1945-1949. PubMed ID: 30218188
[TBL] [Abstract][Full Text] [Related]
33. Home-management of malignant pleural effusion with an indwelling pleural catheter: ten years experience.
Bertolaccini L; Viti A; Gorla A; Terzi A
Eur J Surg Oncol; 2012 Dec; 38(12):1161-4. PubMed ID: 22959168
[TBL] [Abstract][Full Text] [Related]
34. The Relationship of Pleural Manometry With Postthoracentesis Chest Radiographic Findings in Malignant Pleural Effusion.
Chopra A; Judson MA; Doelken P; Maldonado F; Rahman NM; Huggins JT
Chest; 2020 Feb; 157(2):421-426. PubMed ID: 31472154
[TBL] [Abstract][Full Text] [Related]
35. Predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion.
Fysh ETH; Bielsa S; Budgeon CA; Read CA; Porcel JM; Maskell NA; Lee YCG
Chest; 2015 Jun; 147(6):1629-1634. PubMed ID: 25474713
[TBL] [Abstract][Full Text] [Related]
36. Pleural Fluid Analysis and Pleural Elastance as Predictors of Response to Pleurodesis in Patients With Malignant Pleural Effusion.
Ferreiro L; San José E; Gude F; Valdés L
Arch Bronconeumol (Engl Ed); 2018 Mar; 54(3):163-165. PubMed ID: 28927859
[No Abstract] [Full Text] [Related]
37. [Thoracentesis and pleurodesis in the treatment of pleural effusion. Personal experience].
Pisello F; Geraci G; Sciumè C; Li Volsi F; Platia L; Facella T; Romeo M; Modica G
G Chir; 2008; 29(6-7):299-304. PubMed ID: 18544270
[TBL] [Abstract][Full Text] [Related]
38. Malignant pleural disease: a pragmatic guide to diagnosis.
Chang CH; Ost DE
Curr Opin Pulm Med; 2022 Jul; 28(4):282-287. PubMed ID: 35749791
[TBL] [Abstract][Full Text] [Related]
39. Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer.
Chiang KY; Ho JC; Chong P; Tam TC; Lam DC; Ip MS; Lee YG; Lui MM
Respirology; 2020 Nov; 25(11):1167-1173. PubMed ID: 32249488
[TBL] [Abstract][Full Text] [Related]
40. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.
Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE
Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
